| Typicality: | 0.249 |
| Saliency: | 0.203 |
| in patients with prostate cancer | 6 | other |
| obesity → be associated with → worse outcomes | 5 |
| obesity → be linked to → worse outcomes | 4 |
| negative | neutral | positive |
| 0.841 | 0.143 | 0.015 |
| Raw frequency | 9 |
| Normalized frequency | 0.203 |
| Modifier score | 0.500 |
| Perplexity | 15.685 |